1. Corporate Officers - C
2. Culley Brian M

Insider Trading History of Culley Brian M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Culley Brian M since 2017. This trader's CIK number is 1310683. At the time of last reporting, Culley Brian M was the President and CEO of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX). Also see all insider trading activities at Lineage Cell Therapeutics, Inc..

Note that in the past Culley Brian M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Artemis Therapeutics, Inc. (ATMS) by Culley Brian M

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	ATMS	25,000	$0	0	$0	0	$0

Yearly summary of insider trading at Lineage Cell Therapeutics, Inc. (LCTX) by Culley Brian M

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	LCTX	0	$0	0	$0	31,250	$0
2025	LCTX	0	$0	0	$0	31,249	$0
2024	LCTX	50,000	$34,500	0	$0	31,249	$0
2023	LCTX	0	$0	0	$0	31,249	$0
2022	LCTX	11,650	$17,036	0	$0	46,350	$0
2021	LCTX	0	$0	0	$0	30,900	$36,307
2020	LCTX	0	$0	0	$0	61,800	$67,901
2019	LCTX	10,000	$10,100	0	$0	192,700	$0

Insider trading activities at 2 companies by Culley Brian M:

1. Artemis Therapeutics, Inc. (ATMS)

2. Lineage Cell Therapeutics, Inc. (LCTX)

Table 1. Insider trading of Artemis Therapeutics, Inc. (ATMS) by Culley Brian M

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-10-23	ATMS	Buy	25,000	.00	0

Table 2. Insider trading of Lineage Cell Therapeutics, Inc. (LCTX) by Culley Brian M

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-02-11	LCTX	Option Ex	31,250	.00	0
2025-02-11	LCTX	Option Ex	31,249	.00	0
2024-11-21	LCTX	Buy	40,000	.60	24,000
2024-05-24	LCTX	Buy	10,000	1.05	10,500
2024-02-11	LCTX	Option Ex	31,249	.00	0
2023-02-11	LCTX	Option Ex	31,249	.00	0
2022-06-30	LCTX	Option Ex	15,450	.00	0
2022-03-31	LCTX	Buy	6,400	1.53	9,792
2022-03-31	LCTX	Option Ex	15,450	.00	0
2022-03-25	LCTX	Buy	5,250	1.38	7,244
2021-12-31	LCTX	Option Ex	15,450	.00	0
2021-09-30	LCTX	Option Ex	15,450	.00	0
2021-03-31	LCTX	Option Ex	15,450	2.35	36,307
2020-12-31	LCTX	Option Ex	15,450	1.76	27,192
2020-09-30	LCTX	Option Ex	15,450	.94	14,476
2020-06-30	LCTX	Option Ex	15,450	.87	13,441
2020-03-31	LCTX	Option Ex	15,450	.83	12,792
2019-12-31	LCTX	Option Ex	15,450	.00	0
2019-09-30	LCTX	Option Ex	15,450	.00	0
2019-09-17	LCTX	Option Ex	61,800	.00	0
2019-08-13	LCTX	Buy	10,000	1.01	10,100
2019-01-01	BTX	Option Ex	100,000	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Culley Brian M (President and CEO of Lineage Cell Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month